MicroRNA-196a regulates bovine newborn ovary homeobox gene (NOBOX) expression during early embryogenesis
© Tripurani et al; licensee BioMed Central Ltd. 2011
Received: 24 January 2011
Accepted: 6 May 2011
Published: 6 May 2011
Oocyte-derived maternal RNAs drive early embryogenesis when the newly formed embryo is transcriptionally inactive. Recent studies in zebrafish have identified the role of microRNAs during the maternal-to-embryonic transition (MET). MicroRNAs are short RNAs that bind to the 3' UTR of target mRNAs to repress their translation and accelerate their decay. Newborn ovary homeobox gene (NOBOX) is a transcription factor that is preferentially expressed in oocytes and essential for folliculogenesis in mice. NOBOX knockout mice are infertile and lack of NOBOX disrupts expression of many germ-cell specific genes and microRNAs. We recently reported the cloning and expression of bovine NOBOX during early embryonic development and our gene knockdown studies indicate that NOBOX is a maternal effect gene essential for early embryonic development. As NOBOX is a maternal transcript critical for development and NOBOX is depleted during early embryogenesis, we hypothesized that NOBOX is targeted by microRNAs for silencing and/or degradation.
Using an algorithm "MicroInspector", a potential microRNA recognition element (MRE) for miR-196a was identified in the 3' UTR of the bovine NOBOX mRNA. Expression analysis of miR-196a in bovine oocytes and during early embryonic development indicated that it is expressed both in oocytes and embryos and tends to increase at the four-cell and eight-cell stages. Ectopic expression of NOBOX and miR-196a in HeLa cells inhibited the expression of NOBOX protein compared to the control cells without miR-196a. Similarly, the activity of a luciferase construct containing the entire 3' UTR of bovine NOBOX was suppressed, and the regulation was abolished by mutations in the miR-196a binding site indicating that the predicted MRE is critical for the direct and specific binding of miR-196a to the NOBOX mRNA. Furthermore, ectopic expression of miR-196a mimic in bovine early embryos significantly reduced the NOBOX expression at the both mRNA and protein levels.
Collectively, our results demonstrate that miR-196a is a bona fide negative regulator of NOBOX during bovine early embryogenesis.
KeywordsNOBOX bovine oocyte early embryogenesis microRNA maternal to zygotic transition
The earliest stages of embryonic development in vertebrates primarily rely on the maternal RNA and proteins synthesized during oogenesis [1, 2]. The period of maternal control of embryonic development varies among species according to the onset of embryonic genome activation and the degradation of maternal gene products . The major onset of embryonic genome activation begins during the two-cell stage in mice; the four-cell stage in humans, rats and pigs, and during the eight-cell to 16-cell stage in cattle and sheep . Upon fertilization, in mouse embryos, 90 percent of the maternal mRNA is degraded by the two-cell stage, coincident with the complete activation of the embryonic genome [5, 6]. There is direct evidence that maternal mRNA clearance is critical for early embryonic development. For example oocyte-specific c-mos mRNA, essential for regulating meiotic arrest at metaphase, is degraded soon after fertilization and injection of c-mos protein into Xenopus two-cell embryos induces cleavage arrest . In mouse, maternal mRNA degradation is dependent on the 3' untranslated region (3' UTR) of the mRNA transcript. For example, chimeric mRNAs composed of the c-mos coding region fused to the hypoxanthine phosphoribosyltransferase (Hprt) 3' UTR have reduced rates of degradation following microinjection into mouse fertilized oocytes . Thus degradation of maternal mRNAs is critical to embryogenesis and represents a conserved mechanism of vertebrate development.
Multiple negative regulatory mechanisms are critical for post-transcriptional regulation of maternal transcripts, such as transcript deadenylation and interaction with RNA-binding proteins in a nonspecific or sequence-specific fashion . Recent studies in zebrafish have established a role for microRNAs (miRNA) as key regulatory molecules targeting maternal mRNA for degradation during the maternal-to-embryonic transition (MET) . MicroRNAs are endogenous small noncoding RNAs that bind primarily to the 3' UTR of target mRNAs to repress their translation and accelerate their decay . The majority of miRNAs are evolutionarily conserved across species boundaries and play essential roles in regulating many distinct processes such as animal development and growth, cell differentiation, signal transduction, cancer, disease, virus immune defense, programmed cell death, insulin secretion and metabolism [12–14].
In recent years, several studies have revealed the significance of miRNAs in reproduction and embryonic development. For example, targeted disruption of Dicer, a key enzyme involved in miRNA processing and the synthesis of small interfering RNAs from long double-stranded RNA [15, 16] in mice and zebrafish resulted in embryonic lethality due to abnormalities in morphogenesis, cell division and chromosome organization [17–21]. In zebrafish, miR-430 has been linked to maternal mRNA decay accompanying the maternal-to-embryonic transition . At the onset of embryonic genome activation, the level of miR-430 substantially increases and the miRNA targets several hundred maternally provided mRNAs by binding to the complementary sites in their 3' UTR and promotes their deadenylation . Furthermore, miR-196a regulates mammalian development via targeting homoeobox clusters  and misexpression of miR-196a leads to specific eye anomalies in a dose-dependent manner in Xenopus laevis .
Newborn ovary homeobox gene (NOBOX) is a transcription factor, identified by in silico subtraction of expressed sequence tags (ESTs) derived from newborn ovaries in mice . NOBOX mRNA and protein are preferentially expressed in oocytes throughout folliculogenesis . Nobox knockout mice are infertile due to disrupted folliculogenesis and expression of many germ-cell specific genes and miRNAs is perturbed in such animals [25, 26]. Furthermore, mutations in the NOBOX gene associated with premature ovarian failure have been described in humans [27, 28]. We recently established a key role for NOBOX in bovine early embryonic development . Bovine NOBOX is stage-specifically expressed during oocyte maturation and early embryonic development and of maternal origin. Depletion of NOBOX in bovine zygotes by siRNA microinjection impaired embryo development to the blastocyst stage. Furthermore, knockdown of NOBOX affected the expression of genes from the embryonic genome critical to early development and expression of pluripotency genes was altered in the inner cell mass of NOBOX siRNA injected embryos that reached the blastocyst stage. However, despite its established role in folliculogenesis and early embryonic development, the post-transcriptional regulation of NOBOX has not been investigated. Given the importance of NOBOX, as a maternal transcript critical for development, and observed depletion of NOBOX during MET, we hypothesized that NOBOX is targeted by miRNAs for silencing and/or degradation in early embryos. In this study we identified a miRNA (miR-196a) targeting bovine NOBOX, examined the temporal expression of miR-196a during bovine early embryonic development and determined the effect and specificity of miR-196a in regulating bovine NOBOX expression both exogenously (HeLa cells) and endogenously in early embryos.
Results and Discussion
miR-196a binds to the 3' UTR of bovine NOBOX
miR-196a is spatio-temporally regulated during development
miR-196a specifically suppresses the expression of bovine NOBOX
miR-196a represses endogenous NOBOX in bovine early embryos
The degradation of the untranslated maternal RNA pool is very critical to early embryonic development . The translation potential of a maternal mRNA transcript is affected by the length of the poly (A) tail as it confers mRNA stability and stimulates translation via interaction of poly (A) binding protein (PABP) with the 5' m7G cap [44, 45]. Moreover, maternal mRNAs are dependent on post-transcriptional and post-translational mechanisms to regulate their activity, as they cannot be repressed at the transcriptional level [9, 46]. Recent studies in zebrafish and Xenopus found that miRNAs promote deadenylation of target mRNAs and induce maternal mRNA degradation/clearance during early embryogenesis [10, 38], indicating that miRNA-induced clearance of maternal mRNAs might be a universal mechanism during MET. Thus, a similar mechanism is likely to be involved in the miR-196a negative regulation of NOBOX expression in bovine embryos during MET.
miR-196a is an evolutionary conserved miRNA that has been identified in a wide range of vertebrate species. It is expressed from intergenic regions of HOX gene clusters, and targets several HOX genes in these clusters, which are known to play crucial roles during development [22, 47, 48]. Recent studies showed that 75% of tumors express high levels of miR-196a and miR-196a is involved in regulating key pathways such as AKT signaling, p53 and WNT signaling pathways [49, 50]. It has also been reported that miR-196a is differently regulated during polycystic kidney disease suggesting that miR-196 is important for normal functioning of kidney . The involvement of miR-196a in regulating the expression of NOBOX supports a new role of this miRNA in early embryonic development during MET.
Collectively, our results demonstrate the ability of miR-196a to negatively regulate NOBOX expression in a sequence specific fashion and the ability of miR-196a to suppress NOBOX mRNA and protein in early embryos. Future studies of interest will investigate whether loss of miR-196a has any effect on the early embryonic development and identify putative miR-196a targets by next generation sequencing analysis of miR-196a depleted and wild type embryos.
To examine the possibility of NOBOX regulation by miRNAs, we searched for potential microRNA recognition elements (MRE) in the NOBOX 3' UTR using Microinspector http://bioinfo.uni-plovdiv.bg/microinspector/, an algorithm for detection of possible interactions between miRNAs and target mRNA sequences .
Tissue collection, RNA isolation and microRNA expression analysis
Bovine tissue sample collection, total RNA isolation and miRNA expression analysis in multiple tissues, oocytes and early embryos were performed as described previously .
The full-length bovine NOBOX mRNA sequence was amplified from bovine adult ovary cDNA samples by PCR using gene-specific primers containing restriction sites BamHI/XhoI (Additional file 1, Table 1 for the list of primer sequences). The PCR product was digested with BamHI and XhoI enzymes and subsequently cloned into pcDNA3.1 (Invitrogen, Carlsbad, CA) vector digested with the same enzymes. pcDNA3.1: miRNA196a was constructed by PCR amplifying a ~220nt region of genomic sequence surrounding pre-miR-196a from bovine genomic DNA sample using primers containing restriction sites BamHI/XhoI (Additional file 1, Table 1 for the list of primer sequences). The PCR product was digested and subsequently cloned into pcDNA3.1 vector digested with BamHI and XhoI. For construction of a vector containing NOBOX-3' UTR fused to the 3' end of a luciferase reporter, we used the dual luciferase pmirGLO vector (Promega, Madison, WI). The NOBOX 3' UTR was amplified from pcDNA3.1: NOBOX construct using primers containing restriction sites SacI/XbaI (Additional file 1, Table 1 for the list of primer sequences). The PCR product was digested with SacI and XbaI and subsequently cloned into dual luciferase pmirGLO vector digested with the same enzymes. Mutation of the mir-196a miRNA recognition element (MRE) in the NOBOX 3' UTR was performed using the QuickChange site-directed mutagenesis kit (Stratagene, Santaclara, CA) according to the manufacturer's instructions. (Additional file 1, Table 1 for the list of primer sequences).
Cell culture and Reporter assay
HeLa cells were cultured in DMEM (Invitrogen, Carlsbad, CA) containing 10% FBS and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA). For transient transfection, FuGENE6 (Roche Applied Science, Indianapolis, IN) was used according to manufacturer's instructions. Following transfection, cells were incubated for 48 h before harvest for western blotting and luciferase assay. Luciferase assay was performed using the Dual-Glo luciferase assay system (Promega, Madison, WI) as described by the manufacturer. Firefly luciferase activity was normalized to renilla luciferase activity to adjust for variations in transfection efficiency among experiments. All transfection experiments were performed in quadruplicate (n = 4) with data averaged from four independent experiments.
Western blot analysis
Western blot was performed as previously described  with minor modifications. After 48 h of transfection, HeLa cell lysates were harvested and washed once with phosphate-buffered saline (PBS), suspended in 50 μl of PBS, and mixed with an equal volume of Laemmli sample buffer (Bio-Rad, Hercules, CA). Protein samples (15 μg/each) were separated on a 4-20% gradient polyacrylamide gel (Bio-Rad, Hercules, CA) and electroblotted onto a polyvinylindene difluoride (PVDF) membrane (Bio-Rad, Hercules, CA). Following transfer and blocking in 5% nonfat dry milk in Tris-buffered saline containing 0.1% Tween-20 (TBST) for one hour, the membrane was then incubated in NOBOX antibody (ab41612; Abcam, Cambridge, MA) diluted 1:100 in blocking buffer overnight at 4°C. After washing three times with TBST, the membrane was incubated for 1 h with horseradish peroxidase-conjugated goat anti-rabbit IgG (Pierce, Rockford, IL) diluted 1:10 000 in blocking solution. The membrane was washed again with TBST, followed by detection with SuperSignal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL). The membrane was stripped in Restore Plus Western Blot Stripping Buffer (Pierce, Rockford, IL), followed by detection of β-actin (ACTB) protein (positive control) using anti-β-actin antibody (Ambion, Austin, TX) and horseradish peroxidase-conjugated goat anti-mouse IgG (Pierce, Rockford, IL).
Procedures for in vitro maturation of oocytes (obtained from abattoir-derived ovaries) and in vitro fertilization to generate zygotes for microinjection and for subsequent embryo culture were conducted basically as described [54, 55]. Presumptive zygotes collected at 16-18 hours post-fertilization (hpf) were used in all microinjection experiments. Mature miRNA-196a mimic (MIMAT0000226) and negative control cel-miR-67 (CN-001000-01-05) were obtained from Dharmacon Technologies (Dharmacon Inc, Lafayette, CO), and diluted with RNase free water to a final concentration of 10 μM and 20 μM before microinjection (The final concentration used for microinjection was 20 μM based on initial experiments showing this concentration is more effective in repressing Nobox expression). Approximately 20 pl of miRNA mimic (20 μM) was injected into the cytoplasm of zygotes using an inverted Nikon microscope equipped with micromanipulators (Narishige International USA, Inc., East Meadow, NY). Uninjected embryos and embryos injected with above negative control miRNA were used as control groups. Each group contained 25-30 embryos per replicate (n = 4). After microinjection, groups of embryos were cultured in 75- to 90-μl drops of potassium simplex optimization medium (KSOM) (Specialty Media, Phillipsburg, NJ) supplemented with 0.3% bovine serum albumin (BSA) until 72 h after insemination at which time point embryos were collected. The efficiency of NOBOX mRNA/protein knockdown in miRNA-196a mimic injected and control embryos was determined by quantitative real-time PCR analysis and immunocytochemistry in eight-cell stage embryos as described previously . Imaging was performed using confocal spinning-disk microscopy. Optical sections every 1 μm were acquired for each embryo and MetaMorph software (Universal Imaging, Downingtown, PA, USA) was used for image acquisition and analysis.
One-way ANOVA using the general linear models (GLM) procedure of SAS were used to determine the significance of differences in mRNA abundance and between the treated samples and the controls where values resulted from the luciferase reporter assay, quantitative real-time PCR and western blots. Different letters indicate significant differences (P < 0.05).
This work was supported by National Research Initiative Competitive Grant # 2008-35203-19094 from the USDA National Institute of Food and Agriculture (GWS), Agriculture and Food Research Initiative, Competitive Grant # 2009-65203-05706 from the USDA National Institute of Food and Agriculture (JY) and funds from the West Virginia Agricultural and Forestry Experiment Station (Hatch project No. 427). The study is published with the approval of the station director as scientific paper No. 3098.
- Schultz RM: The molecular foundations of the maternal to zygotic transition in the preimplantation embryo. Hum Reprod Update. 2002, 8 (4): 323-331.View ArticlePubMedGoogle Scholar
- Li L, Zheng P, Dean J: Maternal control of early mouse development. Development. 2010, 137 (6): 859-870.PubMed CentralView ArticlePubMedGoogle Scholar
- DeRenzo C, Seydoux G: A clean start: degradation of maternal proteins at the oocyte-to-embryo transition. Trends Cell Biol. 2004, 14 (8): 420-426.View ArticlePubMedGoogle Scholar
- Telford NA, Watson AJ, Schultz GA: Transition from maternal to embryonic control in early mammalian development: a comparison of several species. Mol Reprod Dev. 1990, 26 (1): 90-100.View ArticlePubMedGoogle Scholar
- Bachvarova R, De Leon V, Johnson A, Kaplan G, Paynton BV: Changes in total RNA, polyadenylated RNA, and actin mRNA during meiotic maturation of mouse oocytes. Dev Biol. 1985, 108 (2): 325-331.View ArticlePubMedGoogle Scholar
- Paynton BV, Rempel R, Bachvarova R: Changes in state of adenylation and time course of degradation of maternal mRNAs during oocyte maturation and early embryonic development in the mouse. Dev Biol. 1988, 129 (2): 304-314.View ArticlePubMedGoogle Scholar
- Sagata N, Watanabe N, Vande Woude GF, Ikawa Y: The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs. Nature. 1989, 342 (6249): 512-518.View ArticlePubMedGoogle Scholar
- Alizadeh Z, Kageyama SI, Aoki F: Degradation of maternal mRNA in mouse embryos: selective degradation of specific mRNAs after fertilization. Mol Reprod Dev. 2005, 72 (3): 281-290.View ArticlePubMedGoogle Scholar
- Bettegowda A, Smith GW: Mechanisms of maternal mRNA regulation: implications for mammalian early embryonic development. Front Biosci. 2007, 12: 3713-3726.View ArticlePubMedGoogle Scholar
- Giraldez AJ, Mishima Y, Rihel J, Grocock RJ, Van Dongen S, Inoue K, Enright AJ, Schier AF: Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs. Science. 2006, 312 (5770): 75-79.View ArticlePubMedGoogle Scholar
- Bartel D: MicroRNAs:: Genomics, Biogenesis, Mechanism, and Function. Cell. 2004, 116 (2): 281-297.View ArticlePubMedGoogle Scholar
- Ambros V: The functions of animal microRNAs. Nature. 2004, 431 (7006): 350-355.View ArticlePubMedGoogle Scholar
- He L, Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004, 5 (7): 522-531.View ArticlePubMedGoogle Scholar
- Wienholds E, Plasterk RHA: MicroRNA function in animal development. FEBS Lett. 2005, 579 (26): 5911-5922.View ArticlePubMedGoogle Scholar
- Carmell MA, Hannon GJ: RNase III enzymes and the initiation of gene silencing. Nat Struct Mol Biol. 2004, 11 (3): 214-218.View ArticlePubMedGoogle Scholar
- Jaskiewicz L, Filipowicz W: Role of Dicer in posttranscriptional RNA silencing. Curr Top Microbiol Immunol. 2008, 320: 77-97.PubMedGoogle Scholar
- Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ, Mills AA, Elledge SJ, Anderson KV, Hannon GJ: Dicer is essential for mouse development. Nat Genet. 2003, 35 (3): 215-217.View ArticlePubMedGoogle Scholar
- Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, Jenuwein T, Livingston DM, Rajewsky K: Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Gene Dev. 2005, 19 (4): 489-501.PubMed CentralView ArticlePubMedGoogle Scholar
- Giraldez AJ, Cinalli RM, Glasner ME, Enright AJ, Thomson JM, Baskerville S, Hammond SM, Bartel DP, Schier AF: MicroRNAs regulate brain morphogenesis in zebrafish. Science. 2005, 308 (5723): 833-838.View ArticlePubMedGoogle Scholar
- Tang F, Kaneda M, O'Carroll D, Hajkova P, Barton SC, Sun YA, Lee C, Tarakhovsky A, Lao K, Surani MA: Maternal microRNAs are essential for mouse zygotic development. Genes Dev. 2007, 21 (6): 644-648.PubMed CentralView ArticlePubMedGoogle Scholar
- Nagaraja AK, Andreu-Vieyra C, Franco HL, Ma L, Chen R, Han DY, Zhu H, Agno JE, Gunaratne PH, DeMayo FJ, Matzuk MM: Deletion of Dicer in somatic cells of the female reproductive tract causes sterility. Mol Endocrinol. 2008, 22 (10): 2336-2352.PubMed CentralView ArticlePubMedGoogle Scholar
- Yekta S, Shih IH, Bartel DP: MicroRNA-directed cleavage of HOXB8 mRNA. Science. 2004, 304 (5670): 594-596.View ArticlePubMedGoogle Scholar
- Qiu R, Liu Y, Wu JY, Liu K, Mo W, He R: Misexpression of miR-196a induces eye anomaly in Xenopus laevis. Brain Res Bull. 2009, 79 (1): 26-31.View ArticlePubMedGoogle Scholar
- Suzumori N, Yan C, Matzuk MM, Rajkovic A: Nobox is a homeobox-encoding gene preferentially expressed in primordial and growing oocytes. Mech Dev. 2002, 111 (1-2): 137-141.View ArticlePubMedGoogle Scholar
- Rajkovic A, Pangas SA, Ballow D, Suzumori N, Matzuk MM: NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science. 2004, 305 (5687): 1157-1159.View ArticlePubMedGoogle Scholar
- Choi Y, Qin Y, Berger MF, Ballow DJ, Bulyk ML, Rajkovic A: Microarray analyses of newborn mouse ovaries lacking Nobox. Biol Reprod. 2007, 77 (2): 312-319.View ArticlePubMedGoogle Scholar
- Qin Y, Choi Y, Zhao H, Simpson JL, Chen ZJ, Rajkovic A: NOBOX homeobox mutation causes premature ovarian failure. Am J Hum Genet. 2007, 81 (3): 576-581.PubMed CentralView ArticlePubMedGoogle Scholar
- Qin Y, Shi Y, Zhao Y, Carson SA, Simpson JL, Chen ZJ: Mutation analysis of NOBOX homeodomain in Chinese women with premature ovarian failure. Fertil Steril. 2009, 91 (4 Suppl): 1507-1509.View ArticlePubMedGoogle Scholar
- Tripurani SK, Lee KB, Wang L, Wee G, Smith GW, Lee YS, Latham KE, Yao J: A Novel Functional Role for the Oocyte-Specific Transcription Factor Newborn Ovary Homeobox (NOBOX) during Early Embryonic Development in Cattle. Endocrinology. 2011, 152 (3): 1013-1023.PubMed CentralView ArticlePubMedGoogle Scholar
- Rajewsky N: microRNA target predictions in animals. Nat Genet. 2006, 38 (Suppl): S8-13.View ArticlePubMedGoogle Scholar
- Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell. 2009, 136 (2): 215-233.PubMed CentralView ArticlePubMedGoogle Scholar
- Rusinov V, Baev V, Minkov IN, Tabler M: MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence. Nucleic Acids Res. 2005, W696-700. 33 Web ServerGoogle Scholar
- Brennecke J, Stark A, Russell RB, Cohen SM: Principles of microRNA-target recognition. PLoS Biol. 2005, 3 (3): e85-PubMed CentralView ArticlePubMedGoogle Scholar
- Zuker M: Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Research. 2003, 31 (13): 3406-PubMed CentralView ArticlePubMedGoogle Scholar
- Shen-Orr SS, Pilpel Y, Hunter CP: Composition and regulation of maternal and zygotic transcriptomes reflects species-specific reproductive mode. Genome Biol. 2010, 11 (6): R58-PubMed CentralView ArticlePubMedGoogle Scholar
- Bentwich I: Prediction and validation of microRNAs and their targets. FEBS Lett. 2005, 579 (26): 5904-5910.View ArticlePubMedGoogle Scholar
- Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, Lin C, Socci ND, Hermida L, Fulci V, Chiaretti S, Foà R, Schliwka J, Fuchs U, Novosel A, Müller RU, Schermer B, Bissels U, Inman J, Phan Q, Chien M, Weir DB, Choksi R, De Vita G, Frezzetti D, Trompeter HI, et al: A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007, 129 (7): 1401-1414.PubMed CentralView ArticlePubMedGoogle Scholar
- Lund E, Liu M, Hartley RS, Sheets MD, Dahlberg JE: Deadenylation of maternal mRNAs mediated by miR-427 in Xenopus laevis embryos. RNA. 2009, 15 (12): 2351-2363.PubMed CentralView ArticlePubMedGoogle Scholar
- Krützfeldt J, Poy MN, Stoffel M: Strategies to determine the biological function of microRNAs. Nat Genet. 2006, 38 (Suppl): S14-19.View ArticlePubMedGoogle Scholar
- Begemann G: MicroRNAs and RNA interference in zebrafish development. Zebrafish. 2008, 5 (2): 111-119.View ArticlePubMedGoogle Scholar
- Spruce T, Pernaute B, Di-Gregorio A, Cobb BS, Merkenschlager M, Manzanares M, Rodriguez TA: An early developmental role for miRNAs in the maintenance of extraembryonic stem cells in the mouse embryo. Dev Cell. 2010, 19 (2): 207-219.View ArticlePubMedGoogle Scholar
- Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, Pasquinelli AE: Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell. 2005, 122 (4): 553-563.View ArticlePubMedGoogle Scholar
- Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005, 433 (7027): 769-773.View ArticlePubMedGoogle Scholar
- Curtis D, Lehmann R, Zamore PD: Translational regulation in development. Cell. 1995, 81 (2): 171-178.View ArticlePubMedGoogle Scholar
- Amano: Mechanism of Translation in the period of oocyte to zygote trasition in mammals. JMammOva Res. 2005, 1-11.Google Scholar
- Vasudevan S, Seli E, Steitz JA: Metazoan oocyte and early embryo development program: a progression through translation regulatory cascades. Gene Dev. 2006, 20 (2): 138-146.View ArticlePubMedGoogle Scholar
- Sehm T, Sachse C, Frenzel C, Echeverri K: miR-196 is an essential early-stage regulator of tail regeneration, upstream of key spinal cord patterning events. Dev Biol. 2009, 334 (2): 468-480.View ArticlePubMedGoogle Scholar
- Braig S, Mueller DW, Rothhammer T, Bosserhoff AK: MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma. Cell Mol Life Sci. 2010, 67 (20): 3535-3548.View ArticlePubMedGoogle Scholar
- Andl T, Murchison EP, Liu F, Zhang Y, Yunta-Gonzalez M, Tobias JW, Andl CD, Seykora JT, Hannon GJ, Millar SE: The miRNA-processing enzyme dicer is essential for the morphogenesis and maintenance of hair follicles. Curr Biol. 2006, 16 (10): 1041-1049.PubMed CentralView ArticlePubMedGoogle Scholar
- Schimanski CC, Frerichs K, Rahman F, Berger M, Lang H, Galle PR, Moehler M, Gockel I: High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J Gastroenterol. 2009, 15 (17): 2089-2096.PubMed CentralView ArticlePubMedGoogle Scholar
- Pandey P, Brors B, Srivastava PK, Bott A, Boehn SNE, Groene HJ, Gretz N: Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease. BMC Genomics. 2008, 9: 624-PubMed CentralView ArticlePubMedGoogle Scholar
- Tripurani SK, Xiao C, Salem M, Yao J: Cloning and analysis of fetal ovary microRNAs in cattle. Anim Reprod Sci. 2010, 120 (1-4): 16-22.View ArticlePubMedGoogle Scholar
- Tejomurtula J, Lee KB, Tripurani SK, Smith GW, Yao J: Role of importin alpha8, a new member of the importin alpha family of nuclear transport proteins, in early embryonic development in cattle. Biol Reprod. 2009, 81 (2): 333-342.View ArticlePubMedGoogle Scholar
- Bettegowda A, Patel OV, Ireland JJ, Smith GW: Quantitative analysis of messenger RNA abundance for ribosomal protein L-15, cyclophilin-A, phosphoglycerokinase, beta-glucuronidase, glyceraldehyde 3-phosphate dehydrogenase, beta-actin, and histone H2A during bovine oocyte maturation and early embryogenesis in vitro. Mol Reprod Dev. 2006, 73 (3): 267-278.View ArticlePubMedGoogle Scholar
- Bettegowda A, Yao J, Sen A, Li Q, Lee KB, Kobayashi Y, Patel OV, Coussens PM, Ireland JJ, Smith GW: JY-1, an oocyte-specific gene, regulates granulosa cell function and early embryonic development in cattle. Proc Natl Acad Sci USA. 2007, 104 (45): 17602-17607.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.